Orexigen Reaches Deal With Creditors On $70M DIP Loan
Bankrupt obesity drug maker Orexigen Therapeutics Inc. continued negotiations with noteholders until moments before a hearing Wednesday in Delaware, where it received final court approval on its $70 million post-petition financing...To view the full article, register now.
Already a subscriber? Click here to view full article